High prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in Asia

American Journal of Respiratory and Critical Care Medicine

Volumn 184, Issue 12, 2011, Pages 1409-1417

  Chung, Doo Ryeon ^a,b   Song, Jae Hoon ^a,b   Kim, So Hyun ^b   Thamlikitkul, Visanu ^c   Huang, Shao Guang ^d   Wang, Hui ^e,p   So, Thomas Man Kit ^f   Yasin, Rohani M D ^g   Hsueh, Po Ren ^h   Carlos, Celia C ⁱ   Hsu, Li Yang ^j   Buntaran, Latre ^k   Lalitha, M K ^l   Kim, Min Ja ^m   Choi, Jun Yong ⁿ   Kim, Sang Il ^o   Ko, Kwan Soo ^a,b   Kang, Cheol In ^a   Peck, Kyong Ran ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Asia Pacific Foundation for Infectious Diseases (APFID)   (South Korea)

^c MAHIDOL UNIVERSITY   (Thailand)

^d SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^e PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^f PRINCESS MARGARET HOSPITAL   (Hong Kong)

^g INSTITUTE FOR MEDICAL RESEARCH   (Malaysia)

^h NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

ⁱ RESEARCH INSTITUTE FOR TROPICAL MEDICINE   (Philippines)

^j NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^k NATIONAL CARDIOVASCULAR CENTER HARAPAN KITA   (Indonesia)

^l MADRAS MEDICAL MISSION HOSPITAL   (India)

^m Korea University College of Medicine   (South Korea)

ⁿ Yonsei University College of Medicine   (South Korea)

^o The Catholic University of Korea   (South Korea)

^p PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

more..

Author keywords

Acinetobacter; Drug resistance, microbial; Klebsiella pneumoniae; Pneumonia, ventilator associated; Pseudomonas aeruginosa

Indexed keywords

CEFTOBIPROLE; IMIPENEM; METICILLIN;

ACINETOBACTER; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; ASIA; BACTERIAL PNEUMONIA; BACTERIUM ISOLATE; DISEASE SURVEILLANCE; ENTEROBACTER; ESCHERICHIA COLI; FEMALE; HAEMOPHILUS INFLUENZAE; HOSPITAL ACQUIRED PNEUMONIA; HUMAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; MULTIDRUG RESISTANCE; NONHUMAN; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; SERRATIA MARCESCENS; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA; STREPTOCOCCUS PNEUMONIAE; VENTILATOR ASSOCIATED PNEUMONIA;

ACINETOBACTER; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ASIA; COMORBIDITY; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PNEUMONIA, BACTERIAL; PNEUMONIA, VENTILATOR-ASSOCIATED; PREVALENCE; PROSPECTIVE STUDIES; PSEUDOMONAS AERUGINOSA; RISK FACTORS;

EID: 84155171838     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201102-0349OC     Document Type: Article

References (40)

1. Porzecanski I, Bowton DL. Diagnosis and treatment of ventilator- associated pneumonia. Chest 2006;130:597-604. (Pubitemid 44267034)
2. Kuti JL, Shore E, Palter M, Nicolau DP. Tackling empirical antibiotic therapy for ventilator-associated pneumonia in your ICU: guidance for implementing the guidelines. Semin Respir Crit Care Med 2009;30: 102-115.
3. Leu HS, Kaiser DL, Mori M, Woolson RF, Wenzel RP. Hospital-acquired pneumonia. Attributable mortality and morbidity. Am J Epidemiol 1989;129:1258-1267. (Pubitemid 19148466)
4. Rello J, Ollendorf DA, Oster G, Vera-Llonch M, Bellm L, Redman R, Kollef MH. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002;122:2115-2121. (Pubitemid 36051151)
5. Song JH, Chung DR. Respiratory infections due to drug-resistant bacteria. Infect Dis Clin North Am 2010;24:639-653.
6. Jones RN. Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Clin Infect Dis 2010; 51:S81-S87.
7. Kollef MH, Shorr A, Tabak YP, Gupta V, Liu LZ, Johannes RS. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 2005; 128:3854-3862. (Pubitemid 43062645)
8. Alcon A, Fabregas N, Torres A. Hospital-acquired pneumonia: etiologic considerations. Infect Dis Clin North Am 2003;17:679-695. (Pubitemid 38199835)
9. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002;165:867-903. (Pubitemid 34774654)
10. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect Control Hosp Epidemiol 2000;21:510-515. (Pubitemid 30647154)
11. Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, Wolff M, Spencer RC, Hemmer M. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) study. EPIC International Advisory Committee. JAMA 1995;274:639-644.
12. Luna CM, Aruj P, Niederman MS, Garzon J, Violi D, Prignoni A, Rios F, Baquero S, Gando S. Appropriateness and delay to initiate therapy in ventilator-associated pneumonia. Eur Respir J 2006;27:158-164. (Pubitemid 43092680)
13. Kuti EL, Patel AA, Coleman CI. Impact of inappropriate antibiotic therapy on mortality in patients with ventilator-associated pneumonia and blood stream infection: a meta-analysis. J Crit Care 2008;23:91-100. (Pubitemid 351400347)
14. Kollef MH. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis 2000;31: S131-S138. (Pubitemid 32291120)
15. Song JH. Treatment recommendations of hospital-acquired pneumonia in Asian countries: first consensus report by the Asian HAP working group. Am J Infect Control 2008;36:S83-S92.
16. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171:388-416.
17. Masterton RG, Galloway A, French G, Street M, Armstrong J, Brown E, Cleverley J, Dilworth P, Fry C, Gascoigne AD, et al. Guidelines for the management of hospital-acquired pneumonia in the UK: report of the working party on hospital-acquired pneumonia of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 2008;62:5-34. (Pubitemid 351865870)
18. Rotstein C, Evans G, Born A, Grossman R, Light RB, Magder S, McTaggart B, Weiss K, Zhanel GG. Clinical practice guidelines for hospital-acquired pneumonia and ventilator-associated pneumonia in adults. Can J Infect Dis Med Microbiol 2008;19:19-53. (Pubitemid 351547672)
19. Muscedere J, Dodek P, Keenan S, Fowler R, Cook D, Heyland D. Comprehensive evidence-based clinical practice guidelines for ventilator-associated pneumonia: diagnosis and treatment. J Crit Care 2008;23: 138-147. (Pubitemid 351400356)
20. Song JH and the Asian network for Surveillance of Resistant Pathogens. High frequency of non-fermenters among respiratory isolates from hospital-acquired pneumonia and ventilator-associated pneumonia in Asian countries: an ANSORP study. Presented at the 20th European Congress of Clinical Microbiology and Infectious Diseases. April 10-13, 2010, Vienna, Austria.
21. Chung DR, Song JH, and the Asian network for Surveillance of Resistant Pathogens. Initial empirical antimicrobial therapy and clinical outcome of hospital-acquired pneumonia and ventilator-associated pneumonia in Asian countries: an ANSORP study. Presented at the 20th European Congress of Clinical Microbiology and Infectious Diseases. April 10-13, 2010, Vienna, Austria.
22. Horan T, Gaynes R. Surveillance of nosocomial infections. In: Mayhall C, editor. Hospital epidemiology and infection control, 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2004. p. 1659-1702.
23. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008;36: 309-332. (Pubitemid 351763841)
24. McCabe WR, Jackson GG. Gram-negative bacteremia. I. Etiology and ecology. Arch Intern Med 1962;110:847-853.
25. American College of Chest Physicians/Society of Critical Care Medicine consensus conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-874.
26. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect (In press)
27. Pillar CM, Draghi DC, Sheehan DJ, Sahm DF. Prevalence of multidrug-resistant, methicillin-resistant Staphylococcus aureus in the United States: findings of the stratified analysis of the 2004 to 2005 leader surveillance programs. Diagn Microbiol Infect Dis 2008;60:221-224.
28. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: Twentieth informational supplement. Document M100-S20. Wayne, PA: CLSI; 2010.
29. Chawla R. Epidemiology, etiology, and diagnosis of hospital-acquired pneumonia and ventilator-associated pneumonia in Asian countries. Am J Infect Control 2008;36:S93-S100. (Pubitemid 351632964)
30. Torres A, Ewig S, Lode H, Carlet J. Defining, treating and preventing hospital acquired pneumonia: European perspective. Intensive Care Med 2009;35:9-29.
31. Rello J, Sa-Borges M, Correa H, Leal SR, Baraibar J. Variations in etiology of ventilator-associated pneumonia across four treatment sites: implications for antimicrobial prescribing practices. Am J Respir Crit Care Med 1999;160:608-613. (Pubitemid 29380680)
32. Rello J, Diaz E, Rodriguez A. Etiology of ventilator-associated pneumonia. Clin Chest Med 2005;26:87-95. (Pubitemid 40410707)
33. Park DR. The microbiology of ventilator-associated pneumonia. Respir Care 2005;50:742-763; discussion 763-745.
34. Weber DJ, Rutala WA, Sickbert-Bennett EE, Samsa GP, Brown V, Niederman MS. Microbiology of ventilator-associated pneumonia compared with that of hospital-acquired pneumonia. Infect Control Hosp Epidemiol 2007;28:825-831. (Pubitemid 47055922)
35. Dellit TH, Chan JD, Skerrett SJ, Nathens AB. Development of a guideline for the management of ventilator-associated pneumonia based on local microbiologic findings and impact of the guideline on antimicrobial use practices. Infect Control Hosp Epidemiol 2008;29: 525-533. (Pubitemid 351918031)
36. McDonald LC. Trends in antimicrobial resistance in health care-associated pathogens and effect on treatment. Clin Infect Dis 2006; 42:S65-S71. (Pubitemid 43054217)
37. National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992-June 2001, issued August 2001. Am J Infect Control 2001;29:404-421.
38. Bercault N, Boulain T. Mortality rate attributable to ventilator-associated nosocomial pneumonia in an adult intensive care unit: a prospective case-control study. Crit Care Med 2001;29:2303-2309. (Pubitemid 34038163)
39. Venditti M, Falcone M, Corrao S, Licata G, Serra P. Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia. Ann Intern Med 2009;150:19-26.
40. A randomized trial of diagnostic techniques for ventilator-associated pneumonia. N Engl J Med 2006;355:2619-2630.